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Abstract
Lambda phage vectors mediate gene transfer in cultured mammalian cells and in live mice, and in vivo phage-mediated gene expression is
increased when mice are pre-immunized with bacteriophage lambda. We now show that, like eukaryotic viruses, bacteriophage vectors are subject
to Fc receptor-mediated, antibody-dependent enhancement of infection in mammalian cells. Antibody-dependent enhancement of phage gene
transfer required FcγRI, but not its associated γ-chain, and was not supported by other FcγR family members (FcγRIIA, FcγRIIB, and FcγRIII).
Studies using chlorpromazine and latrunculin A revealed an important role for clathrin-mediated endocytosis (chlorpromazine) and actin filaments
(latrunculin A) in antibody-enhanced phage gene transfer. This was confirmed by experiments using inhibitors of endosomal acidification
(bafilomycin A1, monensin) and by immunocytochemical colocalization of internalized phage particles with early endosome-associated protein-1
(EAA1). In contrast, microtubule-targeting agents (nocodazole, taxol) increased the efficiency of antibody-enhanced phage gene transfer. These
results reveal an unexpected antibody-dependent, FcγRI-mediated enhancement of phage transduction in mammalian cells, and suggest new
approaches to improve bacteriophage-mediated gene transfer.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bacteriophage lambda; Antibody-dependent enhancement; Fc gamma receptor; Gene transfer; Virus vector; Endocytosis; CD64; FcγRI;Microtubule; ActinIntroduction
Bacteriophage lambda is capable of transducing mammalian
cells (Geier and Merril, 1972; Merril et al., 1971), and bac-
teriophage lambda vectors that contain a mammalian gene ex-
pression cassette can express encoded genes in mammalian
target cells, both in vitro (Eguchi et al., 2001; Zanghi et al.,
2007) and in vivo (Clark and March, 2004; Lankes et al., 2007;
March et al., 2004). The ability of lambda phage particles to
transduce mammalian cells in vivo depends only partially on⁎ Corresponding author. Department of Microbiology and Immunology,
University of Rochester, 601 Elmwood Ave, Box 672, Rochester, NY 14642,
USA. Fax: +1 585 473 2361.
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doi:10.1016/j.virol.2007.12.013phagocytic uptake of phage, and is increased when mice are pre-
immunized with bacteriophage lambda (Lankes et al., 2007).
Antibody-dependent enhancement (ADE) of virus infection
is a paradoxical phenomenon in which virus-specific antibodies
fail to completely neutralize virus infectivity, and instead permit
the more efficient infection of susceptible host cells such as
monocytes and macrophages (Takada and Kawaoka, 2003).
This process can be mediated through cellular receptors specific
for the Fc portion of IgG, and has been reported to occur in a
wide range of mammalian viruses and virus infections, in-
cluding dengue virus, HIV-1, influenza virus, measles virus,
murine gamma herpesvirus 68, rabies virus, and yellow fever
virus (among others) (Gotoff et al., 1994; Guillon et al., 2002;
Iankov et al., 2006; Littaua et al., 1990; Peiris and Porterfield,
1979; Porterfield, 1981; Rosa et al., 2007; Schlesinger and
Brandriss, 1981; Takeda et al., 1990, 1988; Tamura et al., 1991,
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occur with mammalian virus vectors, and can lead to enhanced
transduction of antigen-presenting cells by neutralized adeno-
virus-immune complexes, in an Fc receptor-dependent fashion
(Leopold et al., 2006; Mercier et al., 2004).
In the present study, we sought to develop an in vitromodel for
antibody-dependent enhancement of mammalian cells by bacter-
iophageλ vectors, and to determine the underlyingmechanism(s)
involved in this process—including the role of cellular Fc gamma
receptor (FcγR) receptors. FcγRs are expressed on a wide range
of hematopoieitic cells (including B cells, macrophages, mono-
cytes, natural killer cells, and neutrophils), and play an essential
role in the recognition and elimination of immune complexes and
immunoglobulin G (IgG)-opsonized pathogens (Daeron, 1997;
Ravetch and Bolland, 2001). The FcγR family includes both high
affinity receptors (such as FcγRI or CD64) and low affinity
receptors such as FcγRIIA (CD32), and FcγRIII (CD16)
(Ravetch and Bolland, 2001). Binding of immune complexes to
these receptors results in their ligation and in the internalization of
the bound complexes, either via endocytosis (in the case of small/
soluble complexes) or phagocytosis (in the case of IgG-opsonized
microorganisms) (Daeron, 1997; Ravetch and Bolland, 2001).
FcγR cross-linking also results in the activation of cell signaling
and kinase pathways that contribute to phagocytosis and endo-
cytosis, and that mediate the downstream effects of receptor
ligation (such as the degranulation, initiation of host inflammatory
responses and cytokine production) (Huang et al., 2006; Ravetch
and Bolland, 2001).Fig. 1. GpD-specific antiserum enhances λ phage-mediated luciferase expression in F
incubated with various dilutions of a rabbit antiserum raised against the major λ coa
complexes containing phage particles were then added to parental (white bars) or Fcγ
106. Forty-eight hours later, cells were harvested, and luciferase activity was meas
triplicate samples; error bars represent the standard deviation. The data are representat
denote a statistically significant difference from control cells/conditions ( p valueb0A number of FcγRs have been shown to contribute to
antibody-dependent enhancement of virus infection, including
FcγRIA (CD64) and FcγRIIA (CD32) in the case of dengue virus
(Rodrigo et al., 2006; Schlesinger and Chapman, 1999), and
FcγRIIA (CD32) in the case of adenovirus vectors (Leopold et al.,
2006). Our experiments revealed that only FcγRIA, but not other
FcγR family members (FcγRIIA, FcγRIIB and FcγRIIIA), was
capable of supporting antibody-dependent enhancement of
bacteriophage-mediated gene transfer; coexpression of the
FcγR associated γ-chain was not required for ADE. Finally,
studies using pharmacologic inhibitors and immunocytochemical
staining techniques revealed that clathrin-mediated endocytosis
and actin filaments played a critical role in antibody-enhancement
of phage gene transfer, while the microtubule network was found
to play an inhibitory role in this process.
Results
Bacteriophage lambda vectors are capable of transducing
mammalian cells in vivo, and the efficiency of this process is
increased when mice are pre-immunized with lambda phage
particles (Lankes et al., 2007). To investigate the underlying
basis for this observation, we developed an in vitro model for
the antibody-dependent enhancement of lambda phage-
mediated gene expression. Our model comprised (i) a CV1
cell line stably transduced with human FcγRI and its associated
γ-chain (FcγRI γ+ cells), plus (ii) phage-containing immune
complexes that were incubated with these cells. To facilitate thecγRI positive CV1 cells. Luciferase encoding λ phage particles (λ luc) were pre-
t protein, gpD, or with a non-immune pre-bleed from the same animal. Immune
RI γ+ expressing (black bars) CV1 cells, at a multiplicity of infection (MOI) of
ured in cell lysates. The results shown represent mean values calculated from
ive of 3 independent experiments that yielded similar results. The asterisks (⁎⁎⁎)
.001, one-way ANOVA).
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tage of an available phage recombinant containing a luciferase-
encoding mammalian expression cassette [λ(luc)]. These phage
particles were then mixed with a rabbit antiserum directed
against gpD, the major coat protein of bacteriophage λ, in order
to generate phage-containing immune complexes (Fig. 1).
The gpD-specific antiserum was found to significantly en-
hance phage-mediated gene expression in FcγRI γ+ CV1 cells
(which have previously been shown to express high levels of
FcγRI on their surface; Rodrigo et al., 2006), but not in parental
CV1 cells (which do not express FcγRI). This enhancement was
greatest at a low dilution of the antiserum (corresponding to an
estimated molar ratio close to 1 antibody molecule per gpD
monomer on the phage capsid), and declined with serial dilution
of the antibody (Fig. 1). No enhancement was detected when
phage was mixed with serum from the same rabbit, obtained
prior to immunization with lamdba gpD protein (Fig. 1; labeled
as “prebleed”). In light of this result, subsequent experiments
were performed using phage-containing immune complexes
that were prepared using a serum dilution of 1:5.
To confirm that Fc receptor binding was required for the
antibody-dependent enhancement of phage-mediated gene
transfer in FcγRI γ+ CV1 cells, a follow-up experiment was
performed in which the Fc-binding domain of the receptor was
saturated with an FcγRI-specific monoclonal antibody (10.1)
whose binding site overlaps with the Fc-binding site on the
receptor. Cultures treated with this blocking antibody showed a
reduced level of luciferase reporter gene expression following
incubation with phage-containing immune complexes, when
compared with non-treated FcγRI γ+ CV1 cells or cells thatFig. 2. Antibody-dependent enhancement of λ phage-mediated gene expression in F
phage particles either added directly to target cells (λ luc), or were preincubated with a
MOI of 106. In some cases, the parental (white bars) or FcγRI γ+ expressing (blac
blocking antibody, 10.1 (αFcγRI), or IgG1 isotype-matched control antibody (IgG1
hours later, cells were harvested, and luciferase activity was measured in cell lysates. T
bars represent the standard deviation. The data are representative of 3 independent e
significant difference from control cells/conditions ( p valueb0.001, one-way ANOwere treated with an irrelevant, isotype-matched control anti-
body (Fig. 2).
This result demonstrates that antibody-dependent enhance-
ment of phage-mediated gene transfer required the presence
of an Fcγ receptor on the surface of the target cells. Thus,
the enhancement of gene transfer by phage-immune complexes
cannot be attributed to the formation of a dense DNA-phage
precipitate that is more efficiently deposited on cell surfaces
by centrifugation, or non-specifically internalized by target
cells.
We next wished to know whether Fcγ receptors other than
FcγRI might also be capable to permitting antibody-dependent
enhancement of phage-mediated gene transfer. In particular,
although FcγRI binds IgG isotypes with nanomolar affinity, Fc-
binding is not restricted to this receptor, and other receptors
such as FcγRIIA have been implicated in antibody-dependent
enhancement of susceptible cells by dengue virus (Rodrigo
et al., 2006), and by adenovirus vectors (Leopold et al., 2006).
Experiments were therefore performed to assess the ability of
other FcγR family members to support antibody-dependent
enhancement of phage-mediated gene transfer. To do this, COS-
7 cells were transiently transfected with a panel of mammalian
expression plasmids encoding a series of FcγR family mem-
bers, in the presence or absence of the receptor-associated
γ-chain. Surface expression of FcγRs on transiently transfected
COS-7 cells was verified by flow cytometric analysis (Fig. 3A);
γ-chain expression was confirmed by immunoblot analysis of
cell lysates using a γ-chain-specific antibody (Fig. 3B). Stably-
transfected CV1 cells expressing FcγRI and the γ-chain subunit
were used as a positive control for γ-chain expression (Fig. 3B,cγRI-positive CV1 cells requires Fc receptor availability. Luciferase encoding λ
gpD-specific rabbit antiserum (λ luc+αgpD) prior to addition to target cells at a
k bars) CV1 cells were preincubated with 5 μg/ml of a FcγRI ligand-binding
isotype) for 30 min prior to the addition of λ(luc) or λ(luc)+αgpD. Forty-eight
he results shown represent mean values calculated from triplicate samples; error
xperiments that yielded similar results. The asterisks (⁎⁎⁎) denote a statistically
VA).
Fig. 3. FcγRs and associated γ-chains are expressed in transiently transfected COS-7 cells. Mammalian expression plasmid vectors encoding cDNAs corresponding
to FcγRI, FcγRIIA, FcγRIIB, FcγRIII, or the common γ-chain subunit were transiently transfected into COS-7 cells using Lipofectamine-2000. Cells were collected
48-h later and subjected to flow cytometric analysis for cell surface FcγR expression (A) or immunoblot analysis for γ-chain expression (B). (A) Flow histograms are
presented for COS-7 cells that were transiently transfected with expression plasmids encoding the indicated FcγR family members (CD16, CD32A, CD32B, and
CD64); in some cases, cells were also cotransfected with a plasmid encoding the common γ-chain (CD16γ; CD64γ). In each panel, the shaded histogram represents
receptor expression on non-transfected COS-7 cells, the dashed line denotes control staining with an irrelevant isotype-matched antibody, and the open histogram
bounded by the thick solid line represents surface staining for the respective FcγR family member. (B) An immunoblot analysis of common γ-chain expression in the
transfected COS-7 cells is shown. Briefly, lysates were prepared from γ-chain transfected cells, and equal quantities of cell protein were then electrophoretically
separated under reducing conditions, on a 15% SDS polyacrylamide gel. Proteins were then transferred to nitrocellulose, and the membrane was probed with a γ-chain-
specific antibody. Lane 1 represents molecular weight markers (numbers denote the size of selected marker proteins in kilodaltons), while lanes 2–4 show γ-chain
expression in lysates from various transfected cells. Shown are analyses of lysates from: the stably transfected FcγRI γ+ CV1 cell line (lane 2); COS-7 cells transiently
transfected with the CD64 expression plasmid plus the γ-chain expression plasmid (lane 3); or COS-7 cells transiently transfected with the CD16 expression plasmid
plus the γ-chain expression plasmid (lane 4). The expected molecular weight of the common γ-chain is ∼10 kDa.
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and FcγRIII, cell surface expression in the transiently
transfected COS-7 cells was detected even in the absence of a
coexpressed γ-chain cDNA (Fig. 3A). This is consistent with
previous data showing that FcγRI can be expressed on the cell
surface without an absolute requirement for the commonγ-chain
(van Vugt et al., 1999).
Having validated that the desired FcγRs were expressed on
the surface of the transiently transfected COS-7 cells, and that
cytoplasmic receptor-associated γ-chain was also expressed, we
performed gene transfer experiments using phage-containing
immune complexes. As shown in Fig. 4, the only Fc receptor
that supported antibody-dependent enhancement of phage-
mediated gene transfer was FcγRI. Expression of the receptor-
associated γ-chain was not required for this effect. In addition,
the other FcγR family members that were studied (FcγRIIA,FcγRIIB, and FcγRIII [+/- the γ-chain]) all failed to support
antibody-dependent enhancement of phage-mediated gene
transfer (Fig. 4).
To better understand the mechanisms involved in FcγRI-
mediated, antibody-dependent enhancement of phage infectiv-
ity, we employed a panel of pharmacologic agents to dissect the
intracellular mechanisms required for phage-mediated gene
transfer. Drugs known to target clathrin-mediated endocytosis
(chlorpromazine), actin polymerization (latrunculin A, cytocha-
lasin D), and microtubules (nocodazole, taxol) were used in
these experiments.
Chlorpromazine, an inhibitor of clathrin-coated pit formation
at the plasma membrane, significantly decreased phage-mediated
gene expression (Fig. 5A), as did the actin polymerization
inhibitors latrunculin A (Fig. 5A) and cytochalasin D (data not
shown). In contrast, agents that targeted the microtubule network
Fig. 4. Antibody-dependent enhancement of λ phage-mediated gene expression requires FcγRI, but not γ-chain expression, and is not supported by other FcγR family
members. Luciferase encoding λ phage particles either added directly to target cells (λ luc), or were preincubated with a gpD-specific rabbit antiserum (λ luc+αgpD)
prior to addition to target cells at a MOI of 106. Phage were then added to COS-7 cells that had been transiently transfected with mammalian expression plasmids
encoding the indicated FcγR family members (either alone, or in combination with the common γ-chain). Forty-eight hours after the addition of phage, cells were
harvested, and luciferase activity was measured in cell lysates. The data represent mean values calculated from triplicate samples; error bars represent the standard
deviation. The data are representative of 3 independent experiments that yielded similar results. The asterisks (⁎⁎⁎) denote a statistically significant difference from
control cells/conditions ( p valueb0.001, one-way ANOVA).
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plexes. Both nocodazole (a microtubule-depolymerizing agent)
and taxol (paclitaxel; a microtubule-stabilizing agent) augmented
luciferase expression by roughly 10- to 50-fold, in comparison to
non-treated cells (Fig. 5B). These results suggest that the
microtubule network plays an unexpected, inhibitory role in
antibody-dependent enhancement of phage-mediated gene
transfer.
The inhibitory effect of chlorpromazine on gene expression
by phage-immune complexes (Fig. 5A) suggested that these
complexes may enter cells via an endocytic pathway. We there-
fore conducted two sets of follow-up experiments to confirm
this.
First, we performed transduction experiments in the presence
of well-characterized pharmacologic agents that inhibit endo-
somal acidification via different mechanisms. To do this, we
used bafilomycin A, which is an inhibitor of the vacuolar H+-
ATPase (Bowman et al., 1988), and monensin, which is a proton
ionophore (Berg et al., 1983; Harford et al., 1983; Mollenhauer
et al., 1990). Both agents strongly inhibited gene expression by
phage-immune complexes (Fig. 6), without exerting overt cyto-
toxic effects (Table 1).
Second, we conducted immunocytochemical staining experi-
ments to determine whether internalized phage particles were
colocalized with endosomal marker proteins. To do this, cells
were transduced with phage-immune complexes for 10 min, and
then fixed, permeabilized, and stained with antibodies specific
for the major phage coat protein (gpD) or for the early endo-some associated protein (EEA1) (Mu et al., 1995; Simonsen
et al., 1998). The results of this analysis, shown in Fig. 7, reveal
colocalization of phage and EEA1 (see yellow punctate dots in
the “composite” panel). Thus, both sets of follow-up experi-
ments confirmed that phage-immune complexes enter FcγRI-
bearing cells via an endocytic pathway.
Finally, we performed experiments to assess the efficiency of
gene expression by phage-immune complexes. To do this, we
took advantage of an available λ lysogen that contains a phage
genome bearing a mammalian expression cassette encoding the
enhanced GFP reporter gene [λ(GFP)] (Eguchi et al., 2001).
λ(GFP) phage was produced and phage-immune complexes
were used to transduce FcγRI-bearing CV1 cells. The results,
shown in Fig. 8A, reveal that about 1.5% of the cell population
expressed GFP following exposure to λ(GFP) phage-immune
complexes.
In order to directly compare the efficiency of gene transfer
by phage-immune complexes to a standard DNA transfection
methodology, we also performed an experiment in which FcγRI-
bearing CV1 cells were either exposed to λ(luc) phage-immune
complexes or transiently transfected with purified λ(luc) DNA
using a cationic lipid (Lipofectamine2000). This experiment was
conducted in 96-well plates, using our standard phage MOI
(106)—thus, a total of 1010 phage particles were added into each
well. To make the most direct possible comparison with phage-
mediated gene transfer, cells were transiently transfected with an
amount of purified λ(luc) DNA (500 ng) that corresponds to the
DNA content of 1010 phage particles (Lankes et al., 2007).
Fig. 5. Antibody-dependent enhancement of λ phage-mediated gene expression in FcγRI-positive cells is inhibited by chlorpromazine and latrunculin A, but
augmented by nocodazole and taxol. Luciferase encoding λ phage particles were preincubated with a gpD-specific rabbit antiserum (λ luc+αgpD) prior to addition to
target cells at a MOI of 106. Phage was then added to parental CV1 cells (open bars) or to CV1 cells stably expressing FcγRI together with the accessory γ-chain
subunit (black bars; FcγR1 γ+). Cells were pretreated with (A) latrunculin A (2.5 μM), or chlorpromazine (5 μg/ml), or (B) nocodazole (5 μM) or taxol (1 μg/ml and
20 μg/ml), for 30 min at 37 °C before the addition of bacteriophage. As controls, some cells were preincubated in the absence of any exogenous drug, or with DMSO
alone. Forty-eight hours after the addition of phage, cells were harvested, and luciferase activity was measured in cell lysates. The data represent mean values
calculated from triplicate samples; error bars represent the standard deviation. The data are representative of 3 independent experiments that yielded similar results. The
asterisks (⁎⁎, ⁎⁎⁎) denote a statistically significant difference from control cells/conditions ( p valueb0.05[⁎⁎] or p valueb0.001[⁎⁎⁎], one-way ANOVA).
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transfected cells revealed that the efficiency of gene transfer by
phage-immune complexes was within an order of magnitude of
that of lipofectamine-mediated DNA transfection (Fig. 8B).Discussion
This study was designed to understand why prior immuniza-
tion with lambda phage particles results in more efficient lambda
Fig. 6. Antibody-dependent enhancement of λ phage-mediated gene expression in FcγRI-positive cells is prevented by inhibitors of endosomal acidification.
Luciferase encoding λ phage particles were preincubated with a gpD-specific rabbit antiserum (λ luc+αgpD) prior to addition to target cells at an MOI of 106. Phage
was then added to parental CV1 cells (open bars) or to CV1 cells stably expressing FcγRI together with the accessory γ-chain subunit (black bars; FcγR1 γ+). Cells
were pretreated with medium alone (no drug), bafilomycin A1 (20 nM and 100 nM), or monensin (20 μM), for 30 min at 37 °C before the addition of bacteriophage.
Forty-eight hours after the addition of phage, cells were harvested, and luciferase activity was measured in cell lysates. The data represent mean values calculated
from triplicate samples; error bars represent the standard deviation. The asterisks (⁎⁎⁎) denote a statistically significant difference from control cells (no drug)
( p valueb0.001, one-way ANOVA).
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2007). We developed an in vitro model system to study this
phenomenon, and demonstrated that antibody-dependentTable 1
Cell viability is unaffected by pharmacologic agents that modulate antibody-
dependent enhancement of λ phage-mediated gene expression
Drug Parental CV1 FcγRI γ+
No treatment 2.1±0.9 1.5±1.0
Latrunculin A 3.1±2.3 2.9±1.5
Chlorpromazine 3.2±1.4 2.7±1.0
Nocodazole 5.0±1.0 2.6±0.6
Taxol 1 μg/ml 2.0±0.2 1.6±0.6
Taxol 20 μg/ml 3.7±0.5 3.1±0.5
DMSO 2.2±0.1 1.6±0.7
Bafilomycin A1 (20 nM)⁎ 2.8±0.3 2.9±0.1
Bafilomycin A1 (100 nM)⁎ 3.2±0.4 3.1±0.5
Monensin⁎ 4.1±0.4 4.4±0.6
Parental CV1 and FcγRI γ+ cells were treated with the indicated drugs for 48 h.
Drug concentrations were as follows: latrunculin A (2.5 μM), chlorpromazine
(5 μg/ml), nocodazole (5 μM), taxol (1 μg/ml and 20 μg/ml), bafilomycin A
(20 nM and 100 nM), and monensin (20 μM). Cell viability was then measured
by propidium iodide (PI) staining, followed by flow cytometric analysis; data
shown represent the mean percentage of PI-positive cell, as calculated from
three independent experiments (±standard deviation). ⁎: Toxicity of these
compounds was assessed separately from that of the other compounds. In that
separate analysis, PI staining of untreated cells was 1.9±0.2% and 2.1±0.5% for
parental CV1 and FcγRI γ+ cells, respectively.enhancement of phage can occur in susceptible mammalian
cells, via an Fc receptor-mediated process.
In our experiments, expression of FcγRI alone – in the
absence of its associated γ-chain – was sufficient to render cells
susceptible to enhanced transduction by phage-immune com-
plexes. This suggests that gamma chain-mediated signal trans-
duction is not necessary for enhancement of gene transfer by
phage-immune complexes. Prior studies have shown that cells
which express FcγRI in the absence of the γ-chain, or FcγRIIA
with mutations in its cytoplasmic signaling domain, are unable
to phagocytize large particles (Davis et al., 1995; Indik et al.,
1991; Lowry et al., 1998; Odin et al., 1991; Rodrigo et al., 2006;
Van den Herik-Oudijk et al., 1995), although they retain the
ability to take up smaller immune complexes by endocytosis
(Davis et al., 1995; Odin et al., 1991). Thus, the fact that the
γ-chain was not required for FcγRI-mediated enhancement of the
infectivity of phage-containing immune complexes suggests that
FcγRI-mediated phage uptake occurs via an endocytic mechan-
ism, and not via phagocytosis.
This conclusion is supported by the fact that an inhibitor of
clathrin-mediated endocytosis (chlorpromazine) blocked the
antibody-dependent enhancement of phage-mediated gene
transfer. Our results with latrunculin A, nocodazole, and taxol
are also consistent with endocytic uptake of phage-immune
complexes. Actin filaments, but not microtubules, are involved
in clathrin-dependent endocytosis of ligands bound to the cell
surface (Durrbach et al., 1996). In keeping with this, only
Fig. 7. Internalized λ phage-immune complexes colocalize with EEA1 in FcγRI-positive cells. Luciferase encoding λ phage particles were preincubated with a gpD-
specific rabbit antiserum (λ luc+anti αgpD) prior to addition to CV1 cells stably expressing FcγRI together with the accessory γ-chain subunit (FcγR1 γ+) at an MOI
of 106. Cultures were incubated with phage-immune complexes at 4 °C for 1 h to allow binding, and then internalization was permitted by a brief (10 min) incubation at
37 °C. Cells were then fixed, permeabilized, and subjected to immunocytochemical staining. To do this, they were reacted with a polyclonal chicken antiserum directed
against early endosome associated (EEA1) protein (Zymed Laboratories) and a polyclonal rabbit antiserum directed against the major phage capsid protein, gpD.
Bound antibodies were then detected using an Alexa488-conjugated goat anti-chicken IgG (Molecular Probes) and a Texas Red-conjugated donkey anti-rabbit IgG
(Jackson ImmunoResearch). After washing, bound antibodies were visualized using a Nikon C1 visible light scanning confocal microscope. All images were taken
using a 60x/1.4NA objective. A volume-rendered three-dimensional reconstruction of a series of optical sections taken at 0.3 μm steps in the Z dimension was
calculated by the Nikon EZ-C1 analysis software. A representative 0.3 μm Z-stack confocal image, taken through the plane of the cell, is shown. The left panel shows
immunostaining for EEA1 (green), the center panel shows staining for phage (red), and the right panel shows a composite image of the two. Note the abundant yellow
staining, indicating colocalization of phage and EEA1.
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gene transfer by phage-immune complexes; in contrast, no-
codazole or taxol (which target microtubules) augmented the
gene transfer process.
Involvement of an endocytic pathway in uptake of phage-
immune complexes was confirmed by additional studies using
inhibitors of endosomal acidification (bafilomycin A and
monensin), both of which inhibited antibody-dependent en-
hancement of phage-mediated gene transfer, and by direct
observation of phage internalization using immunocytochemical
staining. The latter studies revealed that, at 10 min following
FcγR1-mediated internalization, phage particles were found be
colocalized with the early endosome associated protein, EAA1.
The effects of nocodazole and taxol merit additional dis-
cussion. Both of these agents have been shown to enhance gene
transfection in COS-7 cells mediated by cationic liposomes
(Hasegawa et al., 2001). In addition, nocodazole and other
microtubule-depolymerizing agents have been shown to enhance
gene expression following transfection of vascular smoothmuscle
cells with cationic lipid–DNA complexes (Wang and MacDo-
nald, 2004). Two mechanisms have been proposed to explain
these results: (i) microtubules are required to transport liposome-
DNA complexes to lysosomes in which DNA is degraded and
(ii) the depolymerization of microtubules may lead to activation
of NFκB and increased levels of gene transcription (Hasegawa
et al., 2001; Wang and MacDonald, 2004).
Our results with taxol and nocodazole can best be explained by
a role of microtubules in transporting internalized phage particles
to a lysosomal compartment in which phage are degraded.
This is because we obtained similar results with both taxol (a
microtubule-stabilizing agent) and nocodazole (a microtubule-
depolymerizing agent). Such a finding is inconsistent with a
transcriptional effect on gene expression, since taxol is known to
oppose the positive effects of microtubule-depolymerizing agents
on NFκB activation (Rosette and Karin, 1995). It is, however, ingood agreement with findings reported by Nakanishi and
colleagues, who showed that both taxol and nocodazole interfered
with microtubule-mediated transport of liposome-DNA com-
plexes to lysosomes (Hasegawa et al., 2001).
The fact that phage-immune complex internalization pro-
ceeded via endocytosis rather than phagocytosis is consistent with
recent studies on the Fc receptor-dependent uptake of adenovirus-
immune complexes (Leopold et al., 2006). In contrast, dengue
virus immune complexes have been shown to be internalized by
phagocytosis as well (Rodrigo et al., 2006). The basis for this
discordance is uncertain, but may reflect differences in the sizes
and infectivities of the virus immune complexes (Almeida and
Waterson, 1969; Parren and Burton, 2001).
More unexpected was the observation that phage-immune
complexes led to efficient gene transduction in cells expressing
FcγRI, but not in cells expressing FcγRIIA. FcγRIIA has been
reported to support highly efficient uptake of dengue virus-
immune complexes (Rodrigo et al., 2006), and one might
therefore have expected it to also support the internalization of
phage-immune complexes. Possible reasons for its failure to do
so may again include differences in the sizes or infectivities of
phage-immune complexes versus dengue virus-immune com-
plexes. Whatever the underlying reason, this mechanistic dif-
ference in internalization of phage- versus dengue virus-
immune complexes is consistent with the other fundamental
differences in the uptake of these immune complexes (i.e., the
fact that phage-immune complexes are internalized by an
endocytic pathway, while dengue virus-immune complexes can
enter cells by phagocytosis; Rodrigo et al., 2006).
Fig. 9 presents our working model for antibody-dependent
enhancement of phage-mediated gene transfer. Our data are
consistent with binding of phage-immune complexes to FcγRI,
followed by clathrin-dependent endocytosis. The microtubule
network then appears to play a role in transporting the inter-
nalizing phage particles to late endosomes or lysosomes, in which
Fig. 8. Efficiency of gene transfer by λ phage-immune complexes. (A) CV1 cells stably expressing FcγRI and its associated γ chain (FcγR1 γ+) were mixed with λ(GFP)
particles or λ(GFP) immune complexes at an MOI of 106. Forty-eight hours later, cells were harvested and the number of cells expressing GFP was quantitated by flow
cytometry. (B) CV1FcγR1γ+ cellsweremixedwithλ(luc) particles orλ(luc) immune complexes at anMOI of 106, as described above. In parallel, CV1FcγR1γ+ cellswere
subjected to transient transfection with 500 ng of purified λ(luc) DNA using Lipofectamine2000. (A, B) The data represent mean values calculated from triplicate samples;
error bars represent the standard deviation. The asterisks (⁎⁎⁎) denote a statistically significant difference from all other conditions ( p valueb0.001, one-way ANOVA).
282 R. Sapinoro et al. / Virology 373 (2008) 274–286phage is degraded. This is consistent with the role of microtubules
in transferring vesicular cargo from early endosomes to late
endosomes (Gruenberg et al., 1989). Some phage particles escape
transport to this degradative compartment, and undergo uncoating
and nuclear import—leading to expression of phage-encoded
genes within the transduced mammalian target cell. Since gene
expression is enhanced by 10- to 50-fold by disruption of the
microtubule network, it appears likely that most of the in-
ternalized phage-immune complexes are ultimately destined for
degradation, under normal circumstances.The ability of phage-immune complexes to efficiently
transduce FcγR-bearing mammalian cells has important
implications for phage-mediated gene transfer (Eguchi et al.,
2001; Hajitou et al., 2006; Ivanenkov et al., 1999; Kassner et al.,
1999; Larocca et al., 1999; Sathaliyawala et al., 2006; Zanghi
et al., 2007), and for applications in which phage vectors are
being used to elicit immune responses to encoded or displayed
antigens (Chen et al., 2001; Clark and March, 2004; di Marzo
Veronese et al., 1994; Irving et al., 2001; Jepson and March,
2004; Minenkova et al., 1993; Sathaliyawala et al., 2006). For
Fig. 9. Schematic model for antibody-dependent enhancement ofλ phage-mediated luciferase expression in FcγRI-positive cells. Bacteriophageλ:IgG complex binds and
cross-links FcγRI (1), leading to localization of the bound complex to clathrin-coated pits (2). Clathrin-mediated endocytosis of phage-containing immune complexes then
occurs, in an actin-dependent fashion (3); drugs that block clathrin-mediated endocytosis (chlorpromazine) or actin polymerization (latrunculin A) therefore inhibit phage-
mediated gene transfer. The receptor-associated γ-chain (shown in green in (1)) is not required for receptor-mediated internalization of phage-immune complexes.
Bacteriophage λ is then trafficked to an early endosome/phagosome (4). Phagosome maturation occurs via the transport of early vesicles along microtubules (5) to late
compartments containing degradative enzymes that break down the phage in late endosomes/phagolysosomes (6); drugs that target microtubules (nocodazole, taxol)
therefore augment bacteriophage-mediated transduction. Some partially or fully uncoated phage particles/genomes are presumed to escape the endosome via an undefined
mechanism (7), leading to nuclear import of phage DNA, and subsequent expression of phage-encoded genes (i.e., luciferase) (8).
283R. Sapinoro et al. / Virology 373 (2008) 274–286example, in vaccine applications, it may be beneficial to
generate phage-immune complexes in vitro with the goal of
targeting vector to FcγR-expressing antigen presenting cells
(APC) in vivo. Similarly, it may be possible to generate high-
titer anti-phage antibodies in vivo, and to then use these
antibodies to facilitate vector targeting to FcγR-positive APC.
In conclusion, the results reported here show that, like
mammalian viruses, bacteriophage vectors are subject to Fc
receptor-mediated, antibody-dependent enhancement of infec-
tion. Our findings also show that this process can be used to
increase the efficiency of phage-mediated gene transfer to
FcγR-positive mammalian cells, and provide new insights into
the transduction of mammalian cells by bacteriophage vectors.
Materials and methods
Preparation of bacteriophage lambda lysogens and vector
production
The λD1180(luc) lysogen (Dam15 del EcoRI–SacI cIts857
nin5 Sam100) was a kind gift fromDr. Mahito Nakanishi (Eguchi
et al., 2001). This lysogen contains a firefly luciferase expressioncassette under the transcriptional control of the cytomegalovirus
immediate early promoter. Bacteriophage λD1180(luc) lysogens
were prepared in Top10 (Invitrogen) Escherichia coli (E. coli)
hosts and transformed with a wild-type gpD-containing plasmid,
pTrc-gpD (Zanghi et al., 2005), to produce luciferase-expressing
bacteriophage lambda [λ(luc)]. Induction of the lysogen and
purification of the λ(luc) particles was performed as described
(Zanghi et al., 2005). λ(luc) titers were measured by plaque
forming units (PFU) on LE392 E. coli cells. In some experiments,
λ(GFP) phage was used. In this case, phage was prepared from a
λD1180(GFP) lysogen containing an enhanced GFP expression
cassette under the transcriptional control of the cytomegalovirus
immediate early promoter (Eguchi et al., 2001).
Polyclonal antiserum to gpD
Preparation of a polyclonal antiserum to the major coat
protein of bacteriophage λ has been described (Zanghi et al.,
2005). Briefly, purified gpD protein produced in a bacterial
expression system was injected into rabbits (Sigma Genosys),
and reactivity verified by immunoblot analysis against recom-
binant gpD as well as purified bacteriophage λ particles.
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CV-1 and COS-7 simian-derived kidney cells were obtained
from ATCC and Sigma-Aldrich, respectively. A bi-cistronic
expression plasmid encoding human FcγRI and γ-chain subunit
(FcγRI γ+, clone N′x15) has been described (Rodrigo et al.,
2006); preparation of the CV-1 cells stably transfected with this
plasmid and their interaction with dengue virus immune com-
plexes will be reported elsewhere (Rodrigo et al.). All cells lines
were cultured in Dulbecco'sModified Eagle's Medium (DMEM)
supplemented with 10% fetal bovine serum, and 100 U/ml
penicillin, 100 μg/ml streptomycin, and 2 mM L-glutamine.
FcγRIγ+ cell cultures were maintained in culture media con-
taining 100 μg/ml of hygromycin. Transient transfections were
performed in 12-well tissue culture plates following the manu-
facturer's protocol (Lipofectamine2000; Invitrogen, Carlsbad,
CA). pORF9 expression vectors containing the human FcγRIA,
human FcγRIIA, human FcγRIIB, and murine FcγRIII open
reading frameswere purchased from InvivoGen (SanDiego, CA).
Three micrograms of plasmid DNA, alone or in combination with
a γ-chain expression plasmid (Rodrigo et al., 2006) (as indicated
in the relevant figure legends), was then mixed with transfection
reagent and added to COS-7 monolayers. Forty-eight hours post-
transfection, cells were harvested and then used either (i) to
perform flow cytometric or immunoblot assays (for verification of
FcγR and γ-chain expression), or (ii) to conduct gene transduc-
tion studies using λ(luc) alone or phage-immune complexes.
Analysis of FcγR and γ-subunit expression in transfected COS-7
cells
Cell surface expression of FcγRs was analyzed by flow cyto-
metry. FITC-conjugated monoclonal antibodies specific for
human FcγRI (10.1), human FcγRIIA and FcγRIIB (3D3) or
murine FcγRIII (2.4G2) were used, along with corresponding
isotype-matched control antibodies (mouse IgG1 κ); all antibodies
were purchased from BD Pharmingen (San Jose, CA). A mini-
mum of 10,000 live/gated events were collected for each stained
sample. Expression of the γ-chain subunit was verified by im-
munoblot using a rabbit polyclonal IgG antibody raised against the
γ-subunit of FcεRI (Upstate Cell Signaling Solutions; Lake
Placid, NY), followed by a horseradish peroxidase-linked, donkey
α-rabbit Ig whole antibody (GE Healthcare Life Sciences).
Transduction of cells with λ(luc) or λ(luc)-containing immune
complexes, and quantitation of luciferase activity in lysates
from transduced cells
Cell lines transiently or stably expressing FcγRs (either
alone or in combination with the receptor-associated γ-chain)
were seeded at 1×104 cells/well in a flat-bottom 96-well tissue
culture plate. Non-transfected CV1 and COS-7 cells were used
as negative controls. After incubation overnight, culture me-
dium was removed and replaced with serum-free medium
30 min prior to the addition of λ(luc) or λ(luc)-containing
immune complexes. To generate λ(luc)-containing immune
complexes, λ(luc) particles were mixed with specified dilutionsof the gpD-specific rabbit antiserum (usually 1:5), incubated for
5 min at 37 °C, and then added to tissue culture wells in a total
of 50 μl infection volume.
Transduction of target cells was enhanced using centrifugal
enhancement (“spinoculation”) (Forestell et al., 1996; Hudson
et al., 1976; O'Doherty et al., 2000). Briefly, cell cultures were
centrifuged at 1200 RPM (approximately 1000×g) for 10 min at
37 °C, after addition of phage-immune complexes. Following
centrifugation, cells were incubated for an additional 10 min at
37 °C prior to the addition of 200 μl of serum-containing media,
and incubated for 48 h at 37 °C. To measure luciferase ex-
pression, cells were washed with phosphate buffered saline
(PBS) and lysed in passive lysis buffer (PLB) as instructed by the
manufacturer (Promega). Protein concentration in the resulting
cell lysates was determined by Bradford assay, and equal protein
quantities were used in luciferase assays. Results for luciferase
assays were reported in relative light units.
In Fc-receptor blocking studies, FcγRIγ+ cells were incubated
with an α-FcγRI antibody (10.1) or an isotype-matched control
antibody for 30 min on ice before the addition of phage-immune
complexes; transduction proceeded as described above. In some
experiments, pharmacologic agents were pre-incubated with the
cells 30 min prior to the addition of λ(luc) or λ(luc)-immune
complexes, and remained in the medium for the entire culture
period. The drug concentrations used in the experiments were
titrated on cells and optimal concentrations were selected, based
on doses that did not induce cytotoxicity (Table 1).
Transduction of cells with λ(GFP) or λ(GFP)-containing immune
complexes, and quantitation ofGFP expression in transduced cells
In some experiments, cells were transduced with GFP-en-
coding phage [λ(GFP)]. Transduction was performed using the
same methods described for λ(luc), and protein expression was
quantitated 48 h later, by flow cytometry using a FACScalibur
(Becton-Dickinson).
Transient transfection of cells with purified λ(luc) DNA
In the experiment shown in Fig 8, 104 cells were seeded in 96-
well plates and either transduced with phage-immune complexes
at an MOI of 106, or transiently transfected with purified
genomic DNA prepared from λ(luc) particles, using Lipofecta-
mine2000 (Invitrogen). For transient tranfections, 500 ng of
purified λ(luc) DNA was mixed with Lipofectamine2000 and
incubated for 20 min prior to overlaying on CV1 monolayers
(note that this amount of DNA is equivalent to that contained in
1010 phage particles; Lankes et al., 2007). Mediumwas removed
4 h later and replaced with fresh serum-supplemented DMEM.
Forty-eight hours post-transfection, cells were harvested and
luciferase activity was assessed in cell lysates.
Immunocytochemical staining of cells transduced with
λ(luc)-containing immune complexes
CV1 cells stably expressing FcγRI together with the ac-
cessory γ-chain subunit (FcγR1 γ+) were grown on glass cover
285R. Sapinoro et al. / Virology 373 (2008) 274–286slips. Cover slips were equilibrated on ice for 60 min prior to
exposure to λ(luc)-containing immune complexes at a MOI of
106. Cultures were incubated on ice for an additional 60 min
with phage-immune complexes prior to transferring cover slips
to 37 °C for 10 min. Cover slips were then washed with ice-cold
PBS and fixed with 4% paraformaldehyde. Cells were next
permeabilized with 0.1% Triton X-100 and reacted with a
polyclonal chicken antiserum directed against early endosome
associated (EEA1) protein (Zymed Laboratories, 1:100 dilu-
tion) and a polyclonal rabbit antiserum directed against the
major phage capsid protein, gpD (1:100) for 60 min at room
temperature. After 3 washes with PBS, performed at room tem-
perature for 5 min, the bound primary antibodies were detected
using an Alexa488-conjugated goat anti-chicken IgG (Mole-
cular Probes, 1:100 dilution) and a Texas Red-conjugated
donkey anti-rabbit IgG (Jackson ImmunoResearch, 1:100 dilu-
tion). After washing (as above), bound antibodies were visualized
using a Nikon C1 visible light scanning confocal microscope.
A volume-rendered three-dimensional reconstruction of a series
of optical sections taken at 0.3 μm steps in the Z dimension
was then calculated by the Nikon EZ-C1 analysis software, and
recorded.
Data analysis and biostatistics
All figures show results that are representative of at least
three independent experiments. Data values were calculated
from experimental groups performed in triplicate, and the data
are presented as the mean+ the standard deviation. Data were
analyzed by one-way ANOVA using Prism 4 software
(GraphPad, Inc), followed by Tukey's Multiple Comparison
post-test. A p value of less than 0.05 ( pb0.05) was considered
to be statistically significant.
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